Literature DB >> 24184158

Toxoplasma gondii within skeletal muscle cells: a critical interplay for food-borne parasite transmission.

Izabela J Swierzy1, Maisalreem Muhammad1, Jana Kroll1, Anja Abelmann1, Astrid M Tenter2, Carsten G K Lüder3.   

Abstract

Toxoplasma gondii infects virtually any nucleated cell type of warm-blooded animals and humans including skeletal muscle cells (SkMCs). Infection of SkMCs by T. gondii, differentiation from the highly replicative tachyzoites to dormant bradyzoites and tissue cyst formation are crucial for parasite persistence in muscle tissue. These processes are also prerequisites for one of the major routes of transmission to humans via undercooked or cured meat products. Evidence obtained in vitro and in vivo indicates that SkMCs are indeed a preferred cell type for tissue cyst formation and long-term persistence of T. gondii. This raises intriguing questions about what makes SkMCs a suitable environment for parasite persistence and how the SkMC-T. gondii interaction is regulated. Recent data from our laboratory show that differentiation of SkMCs from myoblasts to syncytial myotubes, rather than the cell type itself, is critical for parasite growth, bradyzoite formation and tissue cyst maturation. Myotube formation is accompanied by a permanent withdrawal from the cell cycle, and the negative cell cycle regulator cell division autoantigen (CDA)-1 directly or indirectly promotes T. gondii stage conversion in SkMCs. Moreover, host cell cycle regulators are specifically modulated in mature myotubes, but not myoblasts, following infection. Myotubes also up-regulate the expression of various pro-inflammatory cytokines and chemokines after T. gondii infection and they respond to IFN-γ by exerting potent anti-parasitic activity. This highlights that mature myotubes are active participants rather than passive targets of the local immune response to T. gondii which may also govern the interaction between SkMCs and the parasite.
Copyright © 2013 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell cycle; Immune response; Myogenesis; Persistence; Skeletal muscle cell; Toxoplasma gondii

Mesh:

Year:  2013        PMID: 24184158     DOI: 10.1016/j.ijpara.2013.10.001

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  15 in total

1.  Regulatory T Cells Promote Myositis and Muscle Damage in Toxoplasma gondii Infection.

Authors:  Richard M Jin; Sarah J Blair; Jordan Warunek; Reid R Heffner; Ira J Blader; Elizabeth A Wohlfert
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

2.  Purification Toxoplasma gondii Tissue Cysts Using Percoll Gradients.

Authors:  Elizabeth A Watts; Animesh Dhara; Anthony P Sinai
Journal:  Curr Protoc Microbiol       Date:  2017-05-16

Review 3.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Vaccination of pigs with the S48 strain of Toxoplasma gondii--safer meat for human consumption.

Authors:  Alison Burrells; Julio Benavides; German Cantón; João L Garcia; Paul M Bartley; Mintu Nath; Jackie Thomson; Francesca Chianini; Elisabeth A Innes; Frank Katzer
Journal:  Vet Res       Date:  2015-05-01       Impact factor: 3.683

5.  Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes.

Authors:  Adrian B Hehl; Walter U Basso; Christoph Lippuner; Chandra Ramakrishnan; Michal Okoniewski; Robert A Walker; Michael E Grigg; Nicholas C Smith; Peter Deplazes
Journal:  BMC Genomics       Date:  2015-02-13       Impact factor: 3.969

6.  Association Between Toxoplasma gondii Exposure and Heart Disease: A Case-Control Study.

Authors:  Cosme Alvarado-Esquivel; Misael Salcedo-Jaquez; Luis Francisco Sanchez-Anguiano; Jesus Hernandez-Tinoco; Elizabeth Rabago-Sanchez; Isabel Beristain-Garcia; Oliver Liesenfeld; Sergio Estrada-Martinez; Alma Rosa Perez-Alamos; Ediyair Alvarado-Soto
Journal:  J Clin Med Res       Date:  2016-03-20

7.  Seroprevalence of Toxoplasma gondii infection and risk factors in domestic sheep in Henan province, central China.

Authors:  Nian Zhang; Shuai Wang; Dong Wang; Chaoying Li; Zhenchao Zhang; Zhijun Yao; Tingting Li; Qing Xie; Shiguo Liu; Haizhu Zhang
Journal:  Parasite       Date:  2016-11-24       Impact factor: 3.000

8.  Opposing Transcriptional Mechanisms Regulate Toxoplasma Development.

Authors:  Dong-Pyo Hong; Joshua B Radke; Michael W White
Journal:  mSphere       Date:  2017-02-22       Impact factor: 4.389

9.  Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.

Authors:  Pengxia Song; Shenyi He; Aihua Zhou; Gang Lv; Jingjing Guo; Jian Zhou; Yali Han; Huaiyu Zhou; Zhen Hao; Hua Cong
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

10.  Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis.

Authors:  Alex Rosenberg; L David Sibley
Journal:  Cell Host Microbe       Date:  2021-05-26       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.